Your browser doesn't support javascript.
loading
Trends in neoadjuvant chemotherapy versus surgery-first in stage I HER2-positive breast cancer patients in the National Cancer DataBase (NCDB).
Zeidman, Michael; Schmidt, Hank; Alberty-Oller, J Jaime; Pisapati, Kereeti V; Ahn, Soojin; Mazumdar, Madhu; Ru, Meng; Moshier, Erin; Port, Elisa.
Afiliação
  • Zeidman M; Dubin Breast Center of the Tisch Cancer Institute, Mount Sinai Hospital, New York, NY, USA. mikezeidman@gmail.com.
  • Schmidt H; Icahn School of Medicine at Mount Sinai, New York, NY, USA. mikezeidman@gmail.com.
  • Alberty-Oller JJ; Dubin Breast Center of the Tisch Cancer Institute, Mount Sinai Hospital, New York, NY, USA.
  • Pisapati KV; Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Ahn S; Dubin Breast Center of the Tisch Cancer Institute, Mount Sinai Hospital, New York, NY, USA.
  • Mazumdar M; Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Ru M; Dubin Breast Center of the Tisch Cancer Institute, Mount Sinai Hospital, New York, NY, USA.
  • Moshier E; Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Port E; Dubin Breast Center of the Tisch Cancer Institute, Mount Sinai Hospital, New York, NY, USA.
Breast Cancer Res Treat ; 187(1): 177-185, 2021 May.
Article em En | MEDLINE | ID: mdl-33392839
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Terapia Neoadjuvante Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Terapia Neoadjuvante Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article